AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
1-Year Return
29.75%
This Quarter Return
+36.42%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$615M
AUM Growth
+$114M
(+23%)
Cap. Flow
-$23.6M
Cap. Flow
% of AUM
-3.84%
Top 10 Holdings %
Top 10 Hldgs %
41%
Holding
112
New
24
Increased
26
Reduced
15
Closed
21
Top Buys
| 1 |
Vera Therapeutics
VERA
|
$20.3M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$16.2M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$12.8M |
| 4 |
AUTL
Autolus Therapeutics
AUTL
|
$11.6M |
| 5 |
Kura Oncology
KURA
|
$11.5M |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
$41.6M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$25.8M |
| 3 |
Viking Therapeutics
VKTX
|
$20.5M |
| 4 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$19M |
| 5 |
LIAN
LianBio American Depositary Shares
LIAN
|
$16.9M |
Sector Composition
| 1 | Healthcare | 92.6% |
| 2 | Financials | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Viridian Therapeutics
VRDN
$1.54B
| – | – |
-50,000
| Closed | -$1.09M |
|
102
SPDR S&P Biotech ETF
XBI
$5.39B
| – | – |
0
| – | – |
|
|
GRTS
103
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – |
0
| – | – |
|
|
CBAY
104
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-1,090,441
| Closed | -$25.8M |
|
|
LIAN
105
DELISTED
LianBio American Depositary Shares
LIAN
| – | – |
-3,779,694
| Closed | -$16.9M |
|
|
IMGN
106
DELISTED
Immunogen Inc
IMGN
| – | – |
-1,404,608
| Closed | -$41.6M |
|
|
ARAV
107
DELISTED
Aravive, Inc. Common Stock
ARAV
| – | – |
-346,511
| Closed | -$42.9K |
|
|
MRTX
108
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-100,049
| Closed | -$5.88M |
|